0001901493-22-000002.txt : 20220118 0001901493-22-000002.hdr.sgml : 20220118 20220118114304 ACCESSION NUMBER: 0001901493-22-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220118 DATE AS OF CHANGE: 20220118 EFFECTIVENESS DATE: 20220118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NexPoint Life Sciences DST CENTRAL INDEX KEY: 0001901493 IRS NUMBER: 872823175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-426919 FILM NUMBER: 22534268 BUSINESS ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 BUSINESS PHONE: (833) 697-6246 MAIL ADDRESS: STREET 1: 300 CRESCENT COURT STREET 2: SUITE 700 CITY: DALLAS STATE: TX ZIP: 75201 D/A 1 primary_doc.xml X0708 D/A LIVE 0001901493 NexPoint Life Sciences DST 300 CRESCENT COURT SUITE 700 DALLAS TX TEXAS 75201 (833) 697-6246 DELAWARE None None Other Delaware Statutory Trust true 2021 N/A NexPoint Real Estate Advisors IV, L.P. 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Sponsor of the Issuer Matthew Goetz 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Authorized Signatory of the Issuer Matt McGraner 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Authorized Signatory of the Issuer N/A NREA Casper, LLC 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Manager and Signatory Trustee of the Issuer N/A NREA Casper Investment Co, LLC 300 Crescent Court Suite 700 Dallas TX TEXAS 75201 Executive Officer Contributor of the Issuer Other Real Estate Decline to Disclose 06b true 0001901493-22-000001 2021-12-16 false true false 100000 Emerson Equity LLC 130032 None None 155 Bovet Road Suite 725 San Mateo CA CALIFORNIA 94402 CA CALIFORNIA CO COLORADO false Maxwell Financial Group, Inc. 167863 None None 1590 Rosecrans Avenue Suite D345 Manhattan Beach CA CALIFORNIA 90266 CA CALIFORNIA false TCFG Wealth Management, LLC 164153 None None 28202 Cabot Road Suite 300 Laguna Niguel CA CALIFORNIA 92677 FL FLORIDA false Great Point Capital LLC 114203 None None 200 West Jackson Boulevard Suite 1000 Chicago IL ILLINOIS 60606 IL ILLINOIS ME MAINE false Centaurus Financial, Inc. 30833 None None 2300 E. Katella Avenue Suite 200 Anaheim CA CALIFORNIA 92806 CA CALIFORNIA UT UTAH false Concorde Investment Services LLC 151604 None None 19500 Victor Parkway Suite 550 Livonia MI MICHIGAN 48152 CA CALIFORNIA IN INDIANA NV NEVADA UT UTAH false Stax Capital 300607 None None 7960 Entrada Lazanja San Diego CA CALIFORNIA 92127 NV NEVADA OR OREGON false Thornhill Securities, Inc. 22333 None None 400 W. 15th Street Suite 700 Austin TX TEXAS 78701 CA CALIFORNIA KS KANSAS false Growth Capital Services, Inc. 124658 None None 2093 Philadelphia Pike 4196 Claymont DE DELAWARE 19703 CA CALIFORNIA false Lightpath Capital, Inc. 34617 None None 1650 E. Southlake Boulevard Suite 100 Southlake TX TEXAS 76092 AZ ARIZONA false McDermott Investment Services, LLC 154926 None None 44 East Broad Street 2nd Floor Bethlehem PA PENNSYLVANIA 18018 NJ NEW JERSEY false 107550012 12757040 94792972 Regarding Item 11, the Issuer may accept smaller investments in the Sponsor's sole discretion. false 36 9303076 true 0 true Sales Commissions include estimates of the maximum amount of Selling Commissions and Dealer Fees that may be paid. 3245300 true Item 16 is an estimate of offering expenses and acquisition fees that may accrue to one or more Related Persons. false NexPoint Life Sciences DST /s/ Matt Goetz Matt Goetz Authorized Signatory of the Issuer 2022-01-18